Barchart on MSN
Moderna stock: Is MRNA outperforming the health care sector?
With a market cap of $19.5 billion, Moderna, Inc. (MRNA) is a biotechnology company focused on developing medicines and ...
NEW YORK - Debate over the need for COVID-19 booster shots is clouding the outlook for Moderna Inc's high-flying shares after ...
According to TipRanks.com, Yee is a 2-star analyst with an average return of 0.4% and a 43.5% success rate. Yee covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, ALX ...
Barchart on MSN
MRNA stock alert: Moderna surges on hantavirus vaccine hopes
Moderna (MRNA) stock pushed meaningfully higher on Friday following reports that the biotech giant is leveraging its mRNA platform to develop a vaccine for hantavirus. The news, which arrived after a ...
Bank of America Securities analyst Alec Stranahan maintained a Sell rating on Moderna yesterday and set a price target of $32.00. Claim 55% Off TipRanks. Unlock trusted, data-back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results